发明名称 |
Compositions and methods of altering cholesterol levels |
摘要 |
The present invention relates to compositions, methods and kits using polynucleotides, primary transcripts and mmRNA molecules. |
申请公布号 |
US8980864(B2) |
申请公布日期 |
2015.03.17 |
申请号 |
US201314135887 |
申请日期 |
2013.12.20 |
申请人 |
Moderna Therapeutics, Inc. |
发明人 |
Hoge Stephen G.;de Fougerolles Antonin;Ellsworth Jeff Lynn |
分类号 |
C07H21/02;C12N15/11 |
主分类号 |
C07H21/02 |
代理机构 |
DT Ward, PC |
代理人 |
DT Ward, PC ;Ward Donna T.;Bryan Jennifer F. |
主权项 |
1. A method of reducing serum levels of cholesterol in a subject comprising administering to said subject a modified mRNA encoding a LDLR mutant, said modified mRNA comprising at least one nucleoside modification, wherein said at least one nucleoside modification is 1-methylpseudouridine and wherein said modified mRNA encodes a protein identical to SEQ ID NO: 19 except for one or more substitution mutations that change the identity of one or more amino acids at one or more of positions 316-339 of SEQ ID NO: 19 in combination with an mRNA encoding a CYP7A1 protein, said mRNA comprising the base sequence of SEQ ID NO: 39 except that each thymidine is replaced by a uridine. |
地址 |
Cambridge MA US |